Current global research landscape on COVID-19 and cancer: Bibliometric and visualization analysis

doi:10.5306/wjco.v13.i10.835

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 10

This Article

(209)

(212)

(0)

(13)

(5857)

(6)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Scientometrics

World J Clin Oncol. Oct 24, 2022; 13(10): 835-847
Published online Oct 24, 2022. doi: 10.5306/wjco.v13.i10.835

Table 4 List of the top 10 cited articles for coronavirus disease 2019 studies related to cancer between January 1, 2020, and June 21, 2022

Ranking	Ref.	Title	Year	Source title	Cited by	Impact Index Per Article¹
1^st	Liang et al[46]	“Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China”	2020	The Lancet Oncology	2498	1017.0
2^nd	Zhang et al[47]	“Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China”	2020	Annals of Oncology	859	296.0
3^rd	Tian et al[49]	“Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer”	2020	Journal of Thoracic Oncology	835	315.5
4^th	Kuderer et al[12]	“Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study”	2020	The Lancet	825	292.5
5^th	Dai et al[9]	“Patients with cancer appear more vulnerable to SARS-CoV-2: A multicenter study during the COVID-19 outbreak	2020	Cancer Discovery	774	118.5
6^th	Yu et al[50]	SARS-CoV-2” “Transmission in Patients with Cancer at a Tertiary Care Hospital in Wuhan, China”	2020	JAMA Oncology	659	236.0
7^th	Maringe et al[48]	“The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study”	2020	The Lancet Oncology	579	189.0
8^th	Lee et al[10]	“COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: A prospective cohort study”	2020	The Lancet	574	210.5
9^th	Mehta et al[11]	“Case fatality rate of cancer patients with COVID-19 in a New York Hospital system”	2020	Cancer Discovery	426	158.5
10^th	Feldmann et al[51]	“Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed”	2020	The Lancet	340	140.0

¹The Impact Index Per Article is presented based on Reference Citation Analysis.

Full Size Table

Citation: Zyoud SH, Koni A, Al-Jabi SW, Amer R, Shakhshir M, Al Subu R, Salameh H, Odeh R, Musleh S, Abushamma F, Abu Taha A. Current global research landscape on COVID-19 and cancer: Bibliometric and visualization analysis. World J Clin Oncol 2022; 13(10): 835-847
URL: https://www.wjgnet.com/2218-4333/full/v13/i10/835.htm
DOI: https://dx.doi.org/10.5306/wjco.v13.i10.835

Zyoud SH, Koni A, Al-Jabi SW, Amer R, Shakhshir M, Al Subu R, Salameh H, Odeh R, Musleh S, Abushamma F, Abu Taha A. Current global research landscape on COVID-19 and cancer: Bibliometric and visualization analysis. World J Clin Oncol 2022; 13(10): 835-847 [PMID: 36337308 DOI: 10.5306/wjco.v13.i10.835]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.